针对新冠肺炎患者的新兴治疗策略
Emerging Therapeutic Strategies for COVID-19 patients.
作者信息
Zhu Shudong, Guo Xialing, Geary Kyla, Zhang Dianzheng
机构信息
Argus Pharmaceuticals, Changsha, China.
Department of Bio-Medical Sciences, Philadelphia College of Osteopathic Medicine, Philadelphia, PA USA.
出版信息
Discoveries (Craiova). 2020 Mar 12;8(1):e105. doi: 10.15190/d.2020.2.
Over 100,000 cases of COVID-19 patients infected with the novel coronavirus SARS-COV-2 have been reported worldwide in approximately 2 months, resulting in over 3000 deaths. Potential therapeutic strategies, including remdesivir, chloroquine phosphate, abidol, lopinavir/ritonavir, plasma, antibody, vaccine and stem cells are discussed in this review. With the number of patients increasing daily, there is an urgent need for effective therapeutic intervention.
在大约两个月的时间里，全球已报告了超过10万例感染新型冠状病毒SARS-CoV-2的新冠肺炎患者，导致3000多人死亡。本综述讨论了潜在的治疗策略，包括瑞德西韦、磷酸氯喹、阿比多尔、洛匹那韦/利托那韦、血浆、抗体、疫苗和干细胞。随着患者数量每日增加，迫切需要有效的治疗干预措施。
Zotero 插件